News Vadadustat Noninferior to Darbepoetin in CKD Publish Date September 10, 2020 Despite favorable efficacy data, the HIF-PHI failed to demonstrate noninferiority to the ESA in patients with CKD with respect to the primary MACE safety endpoint.
